Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

TXMD

TherapeuticsMD (TXMD)

TherapeuticsMD Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TXMD
DateHeureSourceTitreSymboleSociété
14/06/202423h00Edgar (US Regulatory)Form AW - Amendment Withdrawal RequestNASDAQ:TXMDTherapeuticsMD Inc
10/05/202422h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXMDTherapeuticsMD Inc
10/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
10/05/202422h05Business WireTherapeuticsMD Announces First Quarter 2024 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/03/202421h00Business WireTherapeuticsMD Announces Full Year 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
07/12/202322h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
06/12/202317h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXMDTherapeuticsMD Inc
17/11/202315h28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
14/11/202322h05Business WireTherapeuticsMD Announces Third Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
21/08/202322h20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
14/08/202312h50Business WireTherapeuticsMD Announces Second Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/06/202323h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXMDTherapeuticsMD Inc
28/06/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202323h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202323h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202322h38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202322h05Business WireTherapeuticsMD Announces First Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
04/05/202322h40Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TXMDTherapeuticsMD Inc
01/05/202323h03Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202322h48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202322h01Business WireTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model TransitionNASDAQ:TXMDTherapeuticsMD Inc
31/03/202323h04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TXMDTherapeuticsMD Inc
13/02/202323h25Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:TXMDTherapeuticsMD Inc
06/01/202323h31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:TXMDTherapeuticsMD Inc
03/01/202312h50Business WireTherapeuticsMD Completes Transaction to License Its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
05/12/202208h39TipRanksTherapeuticsMD Inks Licensing Deal with Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
05/12/202200h00Business WireTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
14/11/202223h23Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:TXMDTherapeuticsMD Inc
14/11/202222h05Business WireTherapeuticsMD Announces Third Quarter 2022 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
31/10/202211h50Business WireTherapeuticsMD Announces Additional $7 Million Private PlacementNASDAQ:TXMDTherapeuticsMD Inc
 Showing the most relevant articles for your search:NASDAQ:TXMD